Cargando…

Adverse drug reactions to anticoagulants in Spain: analysis of the Spanish National Hospital Discharge Data (2010–2013)

OBJECTIVE: To describe and analyse hospitalisations for adverse drug reactions (ADRs) involving anticoagulants. We also analysed the progress of the reactions over time, the factors related with ADRs. DESIGN: A retrospective, descriptive, epidemiological study. SETTING: This study used the Spanish N...

Descripción completa

Detalles Bibliográficos
Autores principales: Carrasco-Garrido, P, Hernández-Barrera, V, Esteban-Hernández, J, Jiménez-Trujillo, I, Álvaro-Meca, A, López de Andrés, A, de Miguel Diez, J, Rodríguez Barrios, J M, Muñoz Robles, J A, Jiménez-García, R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5253537/
https://www.ncbi.nlm.nih.gov/pubmed/28073793
http://dx.doi.org/10.1136/bmjopen-2016-013224
_version_ 1782498176758972416
author Carrasco-Garrido, P
Hernández-Barrera, V
Esteban-Hernández, J
Jiménez-Trujillo, I
Álvaro-Meca, A
López de Andrés, A
de Miguel Diez, J
Rodríguez Barrios, J M
Muñoz Robles, J A
Jiménez-García, R
author_facet Carrasco-Garrido, P
Hernández-Barrera, V
Esteban-Hernández, J
Jiménez-Trujillo, I
Álvaro-Meca, A
López de Andrés, A
de Miguel Diez, J
Rodríguez Barrios, J M
Muñoz Robles, J A
Jiménez-García, R
author_sort Carrasco-Garrido, P
collection PubMed
description OBJECTIVE: To describe and analyse hospitalisations for adverse drug reactions (ADRs) involving anticoagulants. We also analysed the progress of the reactions over time, the factors related with ADRs. DESIGN: A retrospective, descriptive, epidemiological study. SETTING: This study used the Spanish National Hospital Discharge Database (Conjunto Mínimo Básico de Datos, CMBD), over a 4-year period. PARTICIPANTS: We selected CMBD data corresponding to hospital discharges with a diagnosis of ADRs to anticoagulants (International Classification of Diseases-Ninth Revision, Clinical Modification (ICD-9-CM) code E934.2) in any diagnostic field during the study period. MAIN OUTCOME MEASURES: We calculated the annual incidence of ADRs to anticoagulants according to sex and age groups. The median lengths of hospital stay and in-hospital mortality (IHM) were also estimated for each year studied. Bivariate analyses of the changes in variables according to year were based on Poisson regression. IHM was analysed using logistic regression models. The estimates were expressed as ORs and their 95% CI. RESULTS: During the study period, 50 042 patients were hospitalised because of ADRs to anticoagulants (6.38% of all ADR-related admissions). The number of cases increased from 10 415 in 2010 to 13 891 in 2013. Cumulative incidence of ADRs to anticoagulants was significantly higher for men than women and in all age groups. An adjusted multivariate analysis revealed that IHM did not change significantly over time. We observed a statistically significant association between IHM and age, with the highest risk for the ≥85 age group (OR 2.67; 95% CI 2.44 to 2.93). CONCLUSIONS: The incidence of ADRs to anticoagulants in Spain increased from 2010 to 2013, and was significantly higher for men than women and in all age groups. Older patients were particularly susceptible to being hospitalised with an adverse reaction to an anticoagulant.
format Online
Article
Text
id pubmed-5253537
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-52535372017-01-25 Adverse drug reactions to anticoagulants in Spain: analysis of the Spanish National Hospital Discharge Data (2010–2013) Carrasco-Garrido, P Hernández-Barrera, V Esteban-Hernández, J Jiménez-Trujillo, I Álvaro-Meca, A López de Andrés, A de Miguel Diez, J Rodríguez Barrios, J M Muñoz Robles, J A Jiménez-García, R BMJ Open Epidemiology OBJECTIVE: To describe and analyse hospitalisations for adverse drug reactions (ADRs) involving anticoagulants. We also analysed the progress of the reactions over time, the factors related with ADRs. DESIGN: A retrospective, descriptive, epidemiological study. SETTING: This study used the Spanish National Hospital Discharge Database (Conjunto Mínimo Básico de Datos, CMBD), over a 4-year period. PARTICIPANTS: We selected CMBD data corresponding to hospital discharges with a diagnosis of ADRs to anticoagulants (International Classification of Diseases-Ninth Revision, Clinical Modification (ICD-9-CM) code E934.2) in any diagnostic field during the study period. MAIN OUTCOME MEASURES: We calculated the annual incidence of ADRs to anticoagulants according to sex and age groups. The median lengths of hospital stay and in-hospital mortality (IHM) were also estimated for each year studied. Bivariate analyses of the changes in variables according to year were based on Poisson regression. IHM was analysed using logistic regression models. The estimates were expressed as ORs and their 95% CI. RESULTS: During the study period, 50 042 patients were hospitalised because of ADRs to anticoagulants (6.38% of all ADR-related admissions). The number of cases increased from 10 415 in 2010 to 13 891 in 2013. Cumulative incidence of ADRs to anticoagulants was significantly higher for men than women and in all age groups. An adjusted multivariate analysis revealed that IHM did not change significantly over time. We observed a statistically significant association between IHM and age, with the highest risk for the ≥85 age group (OR 2.67; 95% CI 2.44 to 2.93). CONCLUSIONS: The incidence of ADRs to anticoagulants in Spain increased from 2010 to 2013, and was significantly higher for men than women and in all age groups. Older patients were particularly susceptible to being hospitalised with an adverse reaction to an anticoagulant. BMJ Publishing Group 2017-01-10 /pmc/articles/PMC5253537/ /pubmed/28073793 http://dx.doi.org/10.1136/bmjopen-2016-013224 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
spellingShingle Epidemiology
Carrasco-Garrido, P
Hernández-Barrera, V
Esteban-Hernández, J
Jiménez-Trujillo, I
Álvaro-Meca, A
López de Andrés, A
de Miguel Diez, J
Rodríguez Barrios, J M
Muñoz Robles, J A
Jiménez-García, R
Adverse drug reactions to anticoagulants in Spain: analysis of the Spanish National Hospital Discharge Data (2010–2013)
title Adverse drug reactions to anticoagulants in Spain: analysis of the Spanish National Hospital Discharge Data (2010–2013)
title_full Adverse drug reactions to anticoagulants in Spain: analysis of the Spanish National Hospital Discharge Data (2010–2013)
title_fullStr Adverse drug reactions to anticoagulants in Spain: analysis of the Spanish National Hospital Discharge Data (2010–2013)
title_full_unstemmed Adverse drug reactions to anticoagulants in Spain: analysis of the Spanish National Hospital Discharge Data (2010–2013)
title_short Adverse drug reactions to anticoagulants in Spain: analysis of the Spanish National Hospital Discharge Data (2010–2013)
title_sort adverse drug reactions to anticoagulants in spain: analysis of the spanish national hospital discharge data (2010–2013)
topic Epidemiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5253537/
https://www.ncbi.nlm.nih.gov/pubmed/28073793
http://dx.doi.org/10.1136/bmjopen-2016-013224
work_keys_str_mv AT carrascogarridop adversedrugreactionstoanticoagulantsinspainanalysisofthespanishnationalhospitaldischargedata20102013
AT hernandezbarrerav adversedrugreactionstoanticoagulantsinspainanalysisofthespanishnationalhospitaldischargedata20102013
AT estebanhernandezj adversedrugreactionstoanticoagulantsinspainanalysisofthespanishnationalhospitaldischargedata20102013
AT jimeneztrujilloi adversedrugreactionstoanticoagulantsinspainanalysisofthespanishnationalhospitaldischargedata20102013
AT alvaromecaa adversedrugreactionstoanticoagulantsinspainanalysisofthespanishnationalhospitaldischargedata20102013
AT lopezdeandresa adversedrugreactionstoanticoagulantsinspainanalysisofthespanishnationalhospitaldischargedata20102013
AT demigueldiezj adversedrugreactionstoanticoagulantsinspainanalysisofthespanishnationalhospitaldischargedata20102013
AT rodriguezbarriosjm adversedrugreactionstoanticoagulantsinspainanalysisofthespanishnationalhospitaldischargedata20102013
AT munozroblesja adversedrugreactionstoanticoagulantsinspainanalysisofthespanishnationalhospitaldischargedata20102013
AT jimenezgarciar adversedrugreactionstoanticoagulantsinspainanalysisofthespanishnationalhospitaldischargedata20102013